[e-drug] RFI: Nimesulide ADRs? (9)

["Chandra Gulhati" <seeemgee@yahoo.co.uk>]

E-DRUG:  RFI: Nimesulide ADRs? (9)
----------------------------------

dear E-druggers,

Unfortunately many prescriptions in India (may be
elsewhere also) are "incentive-driven." (Reference:
BMJ, April 4, 2004). Nimesulide is a highly profitable
product: 1350% profits to be precise. So there is lot
of money to throw around.

While the Government of India has placed aspirin under
price control, there is no restriction on the price or
profitability of Nimesulide which has no business to
exist in the first place.

Dr. Chandra M. Gulhati
Editor, MIMS INDIA.
(Monthly Index of Medical Specialities)
seeemgee@yahoo.co.uk